CompletedPhase 4

PENG Block vs. ESP Block for Pediatric Hip Surgery

Poland90 participantsStarted 2023-10-17

Plain-language summary

The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries.

Who can participate

Age range2 Months – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: \- pediatric patients aged between 0-12 years who will undergo hip surgery Exclusion Criteria: * a history of chronic pain use of gabapentin/pregabalin for \> 3 months opioid use \> 1 repeated opioid prescription in the last three months * morbid obesity (BMI \> 99th percentile) * Infection at block application area * coagulopathy

What they're measuring

FLACC score

Timeframe: 48 hours after surgery

Trial details

NCT IDNCT06087549

SponsorPoznan University of Medical Sciences

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-23

View on ClinicalTrials.gov More Hip Dysplasia trials